Food and Drug Administration
April 7, 2005
Slides
Topic I: FDA Proposed Strategy for the Reclassification of Catagory IIIA Allergenic Products
FDA Introduction and Overview, Jay Slater, MD (HTM) (PPT)
German Cockroach Allergen Standardization - Progress Report, Jay Slater, MD (HTM) (PPT)
Research Update, Ronald Rabin, MD (HTM) (PPT)
Reclassification of IIIA Allergenic Products, Jay Slater, MD (HTM) (PPT)
FDA's "Critical Path" Initiative, Kathryn Carbone, MD (HTM) (PPT)
Topic II: FDA Critical Path Initiative Update
Clinical Trial Design and Other Statistical Issues, Mary Foulkes, PhD (HTM) (PPT)